• LDS
  • /Medical Tests
  • /HLA-B75 (HLA-B*15:02) Genotyping for Carbamazepine Hypersensitivity

Diseases (2)
Access to HLA-B75 (HLA-B*15:02) Genotyping for Carbamazepine Hypersensitivity is restricted.

Overview
Access to HLA-B75 (HLA-B*15:02) Genotyping for Carbamazepine Hypersensitivity is restricted.

Clinical Utility
Access to HLA-B75 (HLA-B*15:02) Genotyping for Carbamazepine Hypersensitivity is restricted.

Interpretation
Access to HLA-B75 (HLA-B*15:02) Genotyping for Carbamazepine Hypersensitivity is restricted.

Reference Ranges
Access to HLA-B75 (HLA-B*15:02) Genotyping for Carbamazepine Hypersensitivity is restricted.

Methodology
Access to HLA-B75 (HLA-B*15:02) Genotyping for Carbamazepine Hypersensitivity is restricted.

Specimen Collection
Access to HLA-B75 (HLA-B*15:02) Genotyping for Carbamazepine Hypersensitivity is restricted.

Additional Testing
Access to HLA-B75 (HLA-B*15:02) Genotyping for Carbamazepine Hypersensitivity is restricted.

Turnaround Time
Access to HLA-B75 (HLA-B*15:02) Genotyping for Carbamazepine Hypersensitivity is restricted.

CPT
Access to HLA-B75 (HLA-B*15:02) Genotyping for Carbamazepine Hypersensitivity is restricted.

LOINC
Access to HLA-B75 (HLA-B*15:02) Genotyping for Carbamazepine Hypersensitivity is restricted.

ICD10
Access to HLA-B75 (HLA-B*15:02) Genotyping for Carbamazepine Hypersensitivity is restricted.

Additional ICD10
Access to HLA-B75 (HLA-B*15:02) Genotyping for Carbamazepine Hypersensitivity is restricted.

References
Access to HLA-B75 (HLA-B*15:02) Genotyping for Carbamazepine Hypersensitivity is restricted.

Panel Test Components
Access to HLA-B75 (HLA-B*15:02) Genotyping for Carbamazepine Hypersensitivity is restricted.